Nationally, only about 5% of cancer patients participate in clinical trials, with patients representing minorities participating even less. Even when eligible, nearly half of all patients decline participation when asked. The result? Slower accrual, abandonment of studies and less revenue from study sponsors.

To address this, we’ve created CareXplorer, a digital marketing campaign to activate patients into considering oncology clinical trial participation. We provide CareXplorer to oncology providers sites as a turnkey solution.

Digidence develops state-of-the-art software solutions for oncology practices to improve clinical trial accrual, patient outcomes and clinical workflow. Through collaborations across the United States, our products are expertly designed, scientifically tested, and fully utilized by clinicians and patients.

N/A

Protera Health has three core advantages over existing digital MSK solutions on the market:

1) Ability to deliver in-network care through claims/medical expenses via our virtual clinic model (competitors are vendor solutions that do not deliver clinical care nor are able to contract with health insurance)

2) Individualized treatment according to patient reported outcome measures (PROMs), which are robust quality measures for physical function, pain coping, and mental health. We are the only soluton on the market that centers care - and monitors outcomes - by these metrics. 

3) Platform to in-person care, designed to minimize leakage. Protera works with partner health systems to customize the program to include the system's preferred in-person services, such as physical therapy and specialty care.